Can reporting help psoriasis patients take their meds?
NCT ID NCT05570955
First seen Jan 11, 2026 · Last updated May 05, 2026 · Updated 22 times
Summary
This study looks at how well 40 people with moderate-to-severe psoriasis follow their deucravacitinib treatment. Half of the participants will use a special reporting system to help them stay on track, while the other half will not. Researchers will interview patients and use electronic monitors to see who takes their medication as prescribed and how that affects their skin improvement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wake Forest University Health Sciences Department of Dermatology
Winston-Salem, North Carolina, 27157, United States
Conditions
Explore the condition pages connected to this study.